Clarity Pharmaceuticals Revenue

In the fiscal year ending June 30, 2025, Clarity Pharmaceuticals had annual revenue of 9.46M AUD, down -17.76%. Clarity Pharmaceuticals had revenue of 4.77M in the half year ending June 30, 2025, with 17.37% growth.

Revenue

9.46M AUD

Revenue Growth

-17.76%

P/S Ratio

129.33

Revenue / Employee

137.14K AUD

Employees

Market Cap

802.37M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	9.46M	-2.04M	-17.76%
Jun 30, 2024	11.51M	1.71M	17.41%
Jun 30, 2023	9.80M	3.34M	51.74%
Jun 30, 2022	6.46M	3.26M	102.06%
Jun 30, 2021	3.20M	407.65K	14.62%
Jun 30, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Jun 30, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Jun 30, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
BioStem Technologies	292.21M
Vaxart	148.20M
Silence Therapeutics	25.83M
Nuo Therapeutics	2.61M
Northwest Biotherapeutics	937.00K
ZIVO Bioscience	209.03K

Revenue Rankings